Real-World Evidence of Ribociclib Plus Aromatase Inhibitors as First-Line Treatment in Advanced Breast Cancer: The BrasiLEEira Study.
Article in JCO Global Oncology (April 2024)
The most recent citing publications are shown below. View all 92 publications that cite this research output on Dimensions.
Article in JCO Global Oncology (April 2024)
Article in Journal of the American Geriatrics Society (February 2024)
Article in Frontiers in Pain Research (February 2024)